Home Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer
Article
Licensed
Unlicensed Requires Authentication

Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer

  • Barbara Mroczko , Maciej Szmitkowski , Urszula Wereszczynska-Siemiatkowska and Grazyna GrazynaJurkowska
Published/Copyright: June 1, 2005

Abstract

Stem cell factor (SCF)and macrophage-colony stimulating factor (M-CSF)have assumed an increasing importance in cancer biology. In the present study we investigated the serum levels of these cytokines in pancreatic cancer patients in relation to controls and to patients with benign lesions of the pancreas (chronic pancreatitis group). The classical tumor markers, such as carcinoembryonic antigen (CEA)and carbohydrate antigen 19–9 (CA 19–9)were also tested. We compared the serum levels of cytokines with tumor stage. We also defined the receiver-operating characteristics (ROC)curve for cytokines and classical tumor markers. The cytokines were measured in 47 patients with pancreatic cancer, in 27 patients with chronic pancreatitis and in 35 healthy subjects. SCF and M-CSF were determined using enzyme-linked immunosorbent assay (ELISA). CEA and CA 19–9 were measured by microparticle enzyme immunoassay. There were significant differences in the levels of circulating SCF, M-CSF, CEA and CA 19–9 in the pancreatic cancer patients compared to the control group, but only the serum levels of M-CSF, CEA and CA 19–9 were significantly higher in pancreatic cancer patients compared to the pancreatitis group. The levels of cytokines and tumor markers were higher in patients with a more advanced tumor stage. The M-CSF serum levels correlated positively with the tested tumor markers. The M-CSF area under the ROC curve was higher than the SCF area. These results suggest that M-CSF is a better candidate for a pancreatic cancer tumor marker than SCF.

Published Online: 2005-6-1
Published in Print: 2004-3-9

Copyright © 2004 by Walter de Gruyter GmbH & Co. KG

Articles in the same Issue

  1. Phage-displayed recombinant single-chain antibody fragments with high affinity for cholesteryl ester transfer protein (CETP): cDNA cloning, characterization and CETP quantification
  2. Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer
  3. Modulation of plasma fibrinogen levels in acute-phase response after hepatectomy
  4. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus
  5. Expression of activation molecules in neutrophils, monocytes and lymphocytes from patients with unstable angina treated with stent implantation
  6. Acid ribonuclease and alkaline ribonuclease isoenzymes in plasma of patients with decreased glomerular filtration rate
  7. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein
  8. Significance of consecutive international normalized ratio (INR) outcomes using statistical control rules in long-term anticoagulated patients. Optimization of laboratory monitoring and interpretation of borderline measurements
  9. Clinical trials and p-values, beware of the extremes
  10. Age dependence of serum β-N-acetylhexosaminidase (NAG) activity
  11. Elevated plasma total homocysteine in centenarians
  12. New methodology of influential point detection in regression model building for the prediction of metabolic clearance rate of glucose
  13. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors
  14. The glutathione S-transferase polymorphisms in a control population and in Alzheimer's disease patients
  15. Near-patient testing for infection using urinalysis and immuno-chromatography strips
  16. Long-distance mountain biking does not disturb the measurement of total, free or complexed prostate-specific antigen in healthy men
  17. Development of a new colorimetric method for protein S activity measurement
  18. Re.: Correction to the IFCC primary reference method for the measurement of catalytic activity concentration of enzymes at 37C- part 2: reference procedure for the measurement of creatine kinase. Clin Chem Lab Med 2002;40:635-42
  19. Meetings and Awards
Downloaded on 11.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/CCLM.2004.047/html
Scroll to top button